Furthermore, we propose that cancer-associated fibroblasts (CAFs), which are more resistant to radiation and chemotherapy, may serve as a compensatory source of FGF5 in the tumor microenvironment, sustaining tumor cell survival and migration under treatment stress. Here, FGF5 is linked to neoplasm.